Comparison of the effect of cyclic AMP on the content and release of dopamine and 1-methyl-4-phenylpyridinium (MPP+) in PC12 cells

Autonomic and Autacoid Pharmacology

Volumn 22, Issue 5-6, 2002, Pages 277-289

  Ribeiro, L ^a   Azevedo, I ^a   Martel, F ^a  

^a Institute of Pharmacology and Therapeutics   (Portugal)

Author keywords

1 methyl 4 phenylpyridinium; Cyclic AMP; Dopamine; PC12 cells

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; ACETYLCHOLINE; ADRENALIN; BUCLADESINE; CARBACHOL; CARRIER PROTEIN; CYCLIC AMP; DOPAMINE; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; MONOAMINE; NORADRENALIN; POTASSIUM CHLORIDE; RESERPINE; TRITIUM;

ANIMAL CELL; ARTICLE; CELL LEVEL; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG EFFECT; LONG TERM EXPOSURE; NONHUMAN; QUANTITATIVE ANALYSIS; RAT;

1-METHYL-3-ISOBUTYLXANTHINE; 1-METHYL-4-PHENYLPYRIDINIUM; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; CATECHOLAMINES; CELL SURVIVAL; CHROMAFFIN CELLS; CYCLIC AMP; DOPAMINE; DOPAMINE AGENTS; FORSKOLIN; NEOPLASM PROTEINS; PC12 CELLS; PHOSPHODIESTERASE INHIBITORS; POTASSIUM CHLORIDE; RATS; RESERPINE;

EID: 0042123595     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1474-8673.2002.00273.x     Document Type: Article

References (40)

1. BAIZER, L. & WEINER, N. (1985). Nerve growth factor treatment enhances nicotine-stimulated dopamine release and increases in cyclic adenosine 3′: 5′-mono-phosphate levels in PC12 cell cultures. J. Neurosci., 5, 1176-1179.
2. BERGMEYER, H.U. & BERNT, E. (1974). Lactate dehydrogenase. In: Methods in Enzymatic Analysis, (Ed. H.U. BERGMEYER), pp. 574-579. Academic Press, New York.
3. BRADFORD, M.M. (1976). A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
4. BRYAN-LLUKA, L.J., PACZKOWSKY, F.A. & BO¨NISCH, H. (2001). Effects of short- and long-term exposure to c-AMP and c-GMP on the noradrenaline transporter. Neuropharmacology, 40, 607-617.
5. BUNDEY, R.A., JONES, P.G. & KENDALL, D.A. (2000). An investigation of noradrenaline uptake and release by the CATH.a cell line. J. Neurochem., 74, 799-806.
6. BUNN, S.J., O'BRIEN, K.J., BOYD, T.L. & POWIS, D.A. (1992). Pertussis toxin inhibits noradrenaline accumulation by bovine adrenal medullary chromaffin cells. Naunyn-Schmiedeberg's Arch. Pharmacology, 346, 649-656.
7. CHEEK, T.R. & BURGOYNE, R.D. (1987). Cyclic AMP inhibits both nicotine induced actin disassembly and catecholamine secretion from bovine adrenal chromaffin cells. J. Biol. Chem., 262, 11663-11666.
8. CHERN, Y.-J., HERRERA, M., KAO, L.S. & WESTHEAD, E.W. (1987). Inhibition of catecholamine secretion from bovine chromaffin cells by adenosine nucleotides and adenosine. J. Neurochem., 48, 1573-1576.
9. DANIELS, A.J. & REINHARD, J.F. JR. (1988). Energy-driven uptake of the neurotoxin 1-methyl-4-phenylpyridinium into chromaffin granules via the catecholamine transporter. J. Biol. Chem., 263, 5034-5036.
10. DENTON, T. & HOWARD, B.D. (1987). A dopaminergic cell line variant resistant to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J. Neurochem., 49, 622-630.
11. GOTHERT, M. & HENTRICH, F. (1984). Role of cAMP for regulation of impulse-evoked noradrenaline release from the rabbit pulmonary artery and its possible relationship to presynaptic ACTH receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 328, 127-134.
12. GREENE, L.A. & REIN, G. (1977). Release, storage and uptake of catecholamines by a clonal cell line of nerve growth factor (NGF) responsive pheo-chromocytoma cells. Brain Res., 129, 247-263.
13. GREENE, L.A. & TISCHLER, A.S. (1976). Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA, 73, 2424-2428.
14. GUROFF, G., DICKENS, G., END, D. & LONDOS, C. (1981). The action of adenosine analogs on PC12 cells. J. Neurochem., 37, 1431-1437.
15. + in mouse brain. Neurosci. Lett., 101, 83-88.
16. JAVITCH, J.A., D'AMATO, R.J., STRITTMATTER, S.M. & SNYDER, S.H. (1985). Parkinsonism-inducing neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridinium by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA, 82, 2173-2177.
17. KANNER, B.I., FISHKES, H., MARON, R., SHARON, B. & SCHULDINER, S. (1979). Reserpine as a competitive and reversible inhibitor of the catecholamine transporter of bovine chromaffin granules. FEBS Lett., 100, 175-180.
18. KIRSHNER, N., RORIE, M. & KAMIN, D.L. (1963). Inhibition of dopamine uptake in vitro by reserpine administered in vivo. J. Pharmacol. Exp. Ther., 141, 285-289.
19. LEWIS, E.J., HARRINGTON, C. & CHIKARAISHI, D.M. (1987). Transcriptional regulation of the tyrosine hydroxylase gene by glucocorticoid and cyclic AMP. Proc. Natl. Acad. Sci. USA, 84, 3550-3554.
20. MCGEE, R. JR. & LIEPE, B. (1984). Acute elevation of cyclic AMP does not alter the ion-conducting properties of the neuronal nicotinic acetylcholine receptor of PC12 cells. Mol. Pharmacol., 26, 51-56.
21. MARRIOTT, D., ADAMS, M. & BOARDER, M.R. (1988). Effect of forskolin and prostaglandin El on stimulus secretion coupling in cultured bovine adrenal chromaffin cells. J. Neurochem., 50, 616-623.
22. MARTIN, P.T. & KOSHLAND, JR D.E. (1992). Regulation of neurosecretory habituation in PC12 cells: parallel pathways used by cAMP and calcium. Proc. Natl. Acad. Sci. USA, 89, 10257-10261.
23. MELAMED, E., ROSENTHAL, J., COHEN, O., GLOBUS, M. & UZZAN, A. (1985). Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP. Eur. J. Pharmacol., 116, 179-181.
24. MELDOLESI, J., GATTI, G., AMBROSINI, A., POZZAN, T. & WESTHEAD, E.W. (1988). Second-messenger control of catecholamine release from PC12 cells. Biochem. J., 255, 761-768.
25. MELIGENI, J.A., HAYCOCK, J.W., BENNETT, W.F. & WAYMIRE, J.C. (1982). Phosphorylation and activation of tyrosine hydroxylase mediate the cAMP-induced increase in catecholamine biosynthesis in adrenal chromaffin cells. J. Biol. Chem., 257, 12632-12640.
26. MORITA, K., DOHI, T., KITAYAMA, S., KOYAMA, Y. & TSUJIMOTO, A. (1987). Enhancement of stimulation-evoked catecholamine release from cultured bovine adrenal chromaffin cells by forskolin. J. Neurochem., 48, 243-247.
27. NAKANISHI, N., ONOZAWA, S., MATSUMOTO, R., HASEGAWA, H. & YAMADA, S. (1995a). Cyclic AMP-dependent modulation of vesicular monoamine transport in pheochromocytoma cells. J. Neurochem., 64, 600-607.
28. NAKANISHI, N., ONOZAWA, S., MATSUMOTO, R., KURIHARA, K., UEHA, T., HASEGAWA, H. & MINAMI, N. (1995b). Effects of protein kinase inhibitors and protein phosphatase inhibitors on cyclic AMP-dependent down-regulation of vesicular monoamine transport in pheochromocytoma PC12 cells. FEBS Lett., 368, 411-414.
29. PILEBLAD, E. & CARLSSON, A. (1985). Catecholamine-uptake inhibitors prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain. Neuropharmacology, 24, 689-692.
30. RABE, C.S., SCHNEIDER, J. & MCGEE, R. (1982). Enhancement of depolarization-dependent neurosecretion from PC12 cells by forskolin-induced elevation of cyclic AMP. J. Cyclic Nucleotide Res., 8, 371-384.
31. RACE, H.M. & WAGNER, J.A. (1985). Nerve growth factor affects cyclic AMP metabolism, but not by directly stimulating adenylate cyclase activity. J. Neurochem., 44, 1588-1592.
32. REINHARD, J.F., DILIBERTO, E.J., VIVEROS, O.H. & DANIELS, A.J. (1987). Subcellular compartimentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells. Proc. Natl. Acad. Sci. USA, 84, 8160-8164.
33. +). Naunyn-Schmiedeberg's Arch. Pharmacology, 346, 158-165.
34. 3H]-norepinephrine release from rat brain neocortex slices and synaptosomes. J. Neurosci., 5, 2685-2689.
35. 3H]noradrenaline release from rat brain cortex slices. J. Neurochem., 46, 1711-1717.
36. SLOTKIN, T.A. & EDWARDS, K. (1973). Effects of reserpine on the content and properties of rat adrenal medullary storage vesicles. Biochem. Pharmacol., 22, 549-560.
37. VACCARO, K.K., LIANG, B.T., PERELLE, B.A. & PERLMAN, R.L. (1980). Tyrosine 3-monooxygenase regulates catecholamine biosynthesis in pheochromocytoma cells. J. Biol. Chem., 255, 6539-6541.
38. 3H]-noradrenaline release from rat brain slices and on its presynaptic α-adrenergic modulation. J. Neurochem., 39, 349-356.
39. WESSELS-REIKER, M., HAYCOCK, J.W., HOWLETT, A.C. & STRONG, R. (1991). Vasoactive intestinal polypeptide induces tyrosine hydroxylase in PC12 cells. J. Biol. Chem., 266, 9347-9350.
40. WOOTEN, G.F., THOA, N.B., KOPIN, I.J. & AXELROD, J. (1973). Enhanced release of dopamine-beta-hydroxylase and norepinephrine from sympathetic nerves by dibutyryl cyclic adenosine 3′5′-monophosphate and theophylline. Mol. Pharmacol., 9, 178-183.